Valuation: PExA AB

Market Cap 27.06M 2.85M 2.47M 2.31M 2.12M 3.99M 271M 4.05M 10.62M 135M 10.69M 10.46M 451M P/E 2023
-2.18x
P/E 2024 -1.13x
Enterprise Value 21.47M 2.26M 1.96M 1.84M 1.68M 3.17M 215M 3.21M 8.43M 107M 8.48M 8.29M 358M EV / Sales 2023
3.92x
EV / Sales 2024 8.49x
Free-Float
-
Yield 2023 *
-
Yield 2024 -
1 day-1.97%
1 week-16.29%
Current month-9.70%
1 month+11.19%
3 months+56.84%
6 months+75.29%
Current year+98.67%
1 week 0.03
Extreme 0.0292
0.03
1 month 0.03
Extreme 0.027
0.04
Current year 0.01
Extreme 0.012
0.05
1 year 0.01
Extreme 0.009
0.05
3 years 0.01
Extreme 0.0076
0.05
5 years 0.01
Extreme 0.0076
0.05
10 years 0.01
Extreme 0.0076
0.05
Manager TitleAgeSince
Chief Executive Officer 55 -
Chief Tech/Sci/R&D Officer - 2017-12-31
Chief Tech/Sci/R&D Officer 65 2014-12-31
Director TitleAgeSince
Director/Board Member 66 2009-12-31
Chairman 72 2014-01-30
Director/Board Member 73 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.97%-16.29% - - 5.36M
+0.26%+1.73%+27.75%-36.95% 16.48B
-7.73%-4.31%-1.62%+97.57% 1.83B
-6.72%-1.51%-30.38%-80.55% 1.19B
-0.22%-1.52%-35.29%+22.23% 985M
+0.18%+1.92%-42.95%-52.01% 661M
-0.89%+0.60%-47.04%-52.44% 536M
-1.13%+10.66%+74.01%-46.06% 522M
+0.94%+1.89%-49.23%-46.12% 393M
-0.27%-3.15%-14.57%-28.25% 373M
Average -1.49%+1.17%-13.26%-24.73% 2.55B
Weighted average by Cap. -0.68%+1.12%+14.96%-27.00%

Financials

2023 2024
Net sales 2.02M 212K 184K 172K 158K 297K 20.19M 301K 791K 10.09M 796K 779K 33.58M 720K 75.7K 65.69K 61.51K 56.27K 106K 7.21M 108K 282K 3.6M 284K 278K 11.99M
Net income -8.04M -846K -734K -688K -629K -1.19M -80.6M -1.2M -3.16M -40.27M -3.18M -3.11M -134M -10.16M -1.07M -928K -869K -795K -1.5M -102M -1.52M -3.99M -50.88M -4.01M -3.93M -169M
Net Debt -9.6M -1.01M -876K -821K -751K -1.42M -96.2M -1.44M -3.77M -48.06M -3.79M -3.71M -160M -5.59M -588K -511K -478K -437K -826K -56.05M -836K -2.2M -28M -2.21M -2.16M -93.21M
Logo PExA AB
PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.
Employees
3
Date Price Change
26-08-06 0.0298 -1.97%
26-08-05 €0.0304 -0.65%
26-08-04 €0.0306 -1.92%
26-08-03 €0.0312 -5.45%
26-07-31 €0.0330 -5.17%